Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Orchid Pharma

BSE: 524372|NSE: ORCHIDPHAR|ISIN: INE191A01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 27, 15:48
28.40
-0.85 (-2.91%)
VOLUME 51,466
LIVE
NSE
Jul 27, 15:58
28.30
-1.05 (-3.58%)
VOLUME 280,946
Announcements on Orchid Pharma

19th-Jul-2017 18:23Source: BSE

Orchid Pharma- Shareholding for the Period Ended June 30, 2017

Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly

17th-Jul-2017 12:44Source: BSE

Orchid Pharma- Statement Of Investor Complaints For The Quarter Ended June 30,2017

Statement of Investor Complaints during the three months from April 01,2017 to June 30, 2017, pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20...

14th-Jul-2017 19:28Source: BSE

Orchid Pharma- Updates

Intimation regarding Loss of Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015

14th-Jul-2017 17:33Source: BSE

Orchid Pharma- SUBMISSION OF AUDITED FINANCIALS IN THE REVISED FORMAT AS PER SCHEDULE III OF THE COMPANIES ACT,2013

SUBMISSION OF AUDITED FINANCIALS IN THE REVISED FORMAT AS PER SCHEDULE III OF THE COMPANIES ACT,2013

30th-Jun-2017 17:16Source: BSE

Orchid Pharma- Updates

Change in Statutory Auditor

26th-May-2017 18:17Source: BSE

Orchid Pharma- Press Release

Press Release in connection with Audited Financial Results for the year ended March 31, 2017

26th-May-2017 16:33Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on May 26, 2017.

26th-May-2017 16:17Source: BSE

Orchid Pharma- Outcome of Board Meeting

Audited Financial Results for the quarter and year ended March 31, 2017

24th-May-2017 13:23Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange that Orchid has received ANDA approval from US FDA for Aripiprazole Tablets USP, 2 mg , 5Mg, 10mg, 20mg, and 30mg on May 24, 2017.

24th-May-2017 13:08Source: BSE

Orchid Pharma- Updates

ANDA APPROVAL FROM USFDA FOR ARIPIPRAZOLE TABLET

1 2 3 4 5 Next >>
Quick Links for Orchid Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.